And now we have attached the smallest possible fo, with only
font-family="any" which shows the spurious text loss across a page
break. Note that the top of page 2 is slightly indented (not our intent)
and is missing text (in this case the single word "appears").
I'm tempted to include the pdf (generated with 1.1rc1-VHx2) but won't
until I here you're not able to reproduce the problem!
Cheers,
rjs
On 08/15/2012 09:14 AM, Rob Sargent wrote:
Meanwhile...
IT WORKS. I set column-count to 1 and set the (derogatory remark
redacted) MAX_RECOVERY_ATTEMPTS to 10, which was lucky because by the
time I got back to the original document it had 7 text-free pages in
succession.
Now, recall the title of this thread (swapping loss for lose of
course): I had hoped that the two issues were related but no such
luck. I expect to have a funky-font free example by end of day. This
is a real problem here and I have a sinking feeling that I cannot
correct it with layout tricks.
Thanks a ton,
rjs
On 08/15/2012 02:47 AM, Vincent Hennebert wrote:
On 14/08/12 23:20, Glenn Adams wrote:
On Tue, Aug 14, 2012 at 1:23 PM, Vincent Hennebert
<vhenneb...@gmail.com>wrote:
If this is still not enough, then you can change the
MAX_RECOVERY_ATTEMPTS constant in
src/java/org/apache/fop/layoutmgr/BreakingAlgorithm.java to whatever
suits your needs. Note that this constant is also used for line
breaking, so you may want to keep it reasonably low in order to reduce
the impact on performance. Something as small as 10 might be more than
enough for your needs.
Is it worth introducing the ability for the FOP operator to specify the
maximum recovery attempts via fop.xconf? Is it worth dividing this
into two
settings, one for page breaking, another for line breaking?
I don’t think it’s worth the additional complexity of wiring a look-up
to a configuration variable. I’d rather implement a more intelligent
analysis of the page sequence to determine if there will be an infinite
loop or not.
I'd prefer not to have non-configurable magic numbers of this sort if
possible.
Vincent
---------------------------------------------------------------------
To unsubscribe, e-mail: fop-users-unsubscr...@xmlgraphics.apache.org
For additional commands, e-mail: fop-users-h...@xmlgraphics.apache.org
---------------------------------------------------------------------
To unsubscribe, e-mail: fop-users-unsubscr...@xmlgraphics.apache.org
For additional commands, e-mail: fop-users-h...@xmlgraphics.apache.org
<?xml version="1.0" encoding="UTF-8"?>
<fo:root xmlns:fo="http://www.w3.org/1999/XSL/Format"; xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"; xmlns:xalan="http://xml.apache.org/xslt"; xmlns:tags="xalan://com.amirsys.printing.renderer.acres.ProseFigureReference" xmlns:ec="xalan://com.amirsys.utilities.ElementConversion">
<fo:layout-master-set>
<fo:simple-page-master margin="0.0in 0.0in 0.6in 0.833in" page-width="8.5in" page-height="11in" master-name="chapter-refs-right">
<fo:region-body column-gap="0.4in" margin-left="0.7in" margin-top="0.50in" column-count="2" />
<fo:region-before extent="0.50in" column-gap="0.4in" column-count="2" region-name="default-right-header" />
</fo:simple-page-master>
<fo:simple-page-master margin=" 0.0in 0.833in 0.6in 0.0in" page-width="8.5in" page-height="11in" master-name="chapter-refs-left">
<fo:region-body column-gap="0.4in" margin-right="0.7in" margin-top="3in" column-count="2" />
<fo:region-before extent="3in" column-gap="0.4in" column-count="2" region-name="default-left-header" />
</fo:simple-page-master>
<fo:simple-page-master page-width="8.5in" page-height="11in" master-name="two-up-page-3" margin="0.0in 0.0in 0.6in 0.833in">
<fo:region-body margin-right="0.70in" margin-top="4.81in" column-gap="0.40in" column-count="2" />
<fo:region-before precedence="true" extent="4.81in" region-name="header-two-up-page-3" />
</fo:simple-page-master>
<fo:simple-page-master page-width="8.5in" page-height="11in" master-name="three-side-page-4" margin=" 0.0in 0.833in 0.6in 0.0in">
<fo:region-body margin-left="4.3585in" margin-top="0.75in" column-count="1" />
<fo:region-before precedence="true" extent="0.50in" region-name="default-left-header" />
<fo:region-start extent="3.465in" region-name="three-side-start-4" />
</fo:simple-page-master>
<fo:page-sequence-master master-name="document-sequence">
<fo:single-page-master-reference master-reference="two-up-page-3" />
<fo:single-page-master-reference master-reference="three-side-page-4" />
<fo:repeatable-page-master-alternatives>
<fo:conditional-page-master-reference page-position="any" odd-or-even="even" master-reference="chapter-refs-left" blank-or-not-blank="not-blank" />
<fo:conditional-page-master-reference page-position="any" odd-or-even="odd" master-reference="chapter-refs-right" blank-or-not-blank="not-blank" />
</fo:repeatable-page-master-alternatives>
</fo:page-sequence-master>
</fo:layout-master-set>
<fo:page-sequence force-page-count="end-on-even" initial-page-number="1" master-reference="document-sequence">
<fo:static-content flow-name="default-left-header">
<fo:block-container background-color="#FFE8F0" text-indent="0.70in" white-space-collapse="false" height="0.50in" font-size="11pt" font-family="Optima-Oblique">
<fo:block line-height="0.3in" padding-before="0.2in">
<fo:inline>
<fo:page-number />
    Section to be Named Later
</fo:inline>
</fo:block>
</fo:block-container>
</fo:static-content>
<fo:static-content flow-name="default-right-header">
<fo:block-container white-space-collapse="false" last-line-end-indent="0.70in" text-align-last="end" text-align="right" background-color="#FFE8F0" height="0.50in" font-size="11pt" font-family="Optima-Oblique">
<fo:block line-height="0.3in" padding-before="0.2in">
<fo:inline>
Familial Tumor and Neurocutaneous Syndromes
<fo:page-number />
</fo:inline>
</fo:block>
</fo:block-container>
</fo:static-content>
<fo:static-content flow-name="header-two-up-page-3">
<fo:block-container white-space-collapse="false" last-line-end-indent="0.70in" text-align-last="end" text-align="right" background-color="#FFE8F0" height="0.50in" font-size="11pt" font-family="Optima-Oblique">
<fo:block line-height="0.3in" padding-before="0.2in">
<fo:inline>
Familial Tumor and Neurocutaneous Syndromes
<fo:page-number />
</fo:inline>
</fo:block>
</fo:block-container>
<fo:table width="100%" padding-after="2pt" space-before="5pt" border-collapse="separate" table-layout="fixed">
<fo:table-column column-width="3.2585in" />
<fo:table-column column-width="0.4in" />
<fo:table-column column-width="3.2585in" />
<fo:table-column column-width="0.70in" />
<fo:table-body>
<fo:table-row height="8pt">
<fo:table-cell number-columns-spanned="4">
<fo:block />
</fo:table-cell>
</fo:table-row>
<fo:table-row height="3.3085in">
<fo:table-cell>
<fo:block>
<fo:external-graphic border-collapse="separate" border="0.5pt solid black" content-width="scale-to-fit" content-height="scale-to-fit" width="3.2585in" height="3.2585in" src="ref_43_1155183162" />
</fo:block>
</fo:table-cell>
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block>
<fo:external-graphic border-collapse="separate" border="0.5pt solid black" content-width="scale-to-fit" content-height="scale-to-fit" width="3.2585in" height="3.2585in" src="ref_44_695298615" />
</fo:block>
</fo:table-cell>
<fo:table-cell>
<fo:block />
</fo:table-cell>
</fo:table-row>
<fo:table-row height="0.6in">
<fo:table-cell>
<fo:block-container>
<fo:block font-style="italic" font-size="9pt" font-family="TimesNewRomanPSMT">
<fo:inline font-weight="bold">24-3. </fo:inline>
<fo:inline font-weight="normal" margin-left="2pt">Plexiform NF involving cervical nerve roots is depicted on graphic (left), coronal STIR scan (right).</fo:inline>
</fo:block>
</fo:block-container>
</fo:table-cell>
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block-container>
<fo:block font-style="italic" font-size="9pt" font-family="TimesNewRomanPSMT">
<fo:inline font-weight="bold">24-4. </fo:inline>
<fo:inline font-weight="normal" margin-left="2pt">Coronal autopsy (left) and coronal STIR (right) show plexiform NF of thoracolumbar nerve roots (autopsy courtesy R Hewlett, MD).</fo:inline>
</fo:block>
</fo:block-container>
</fo:table-cell>
</fo:table-row>
</fo:table-body>
</fo:table>
</fo:static-content>
<fo:static-content flow-name="three-side-start-4">
<fo:table width="100%" space-before="10pt" table-layout="fixed">
<fo:table-column column-width="0.70in" />
<fo:table-column column-width="2.6in" />
<fo:table-body>
<fo:table-row height="8pt">
<fo:table-cell number-columns-spanned="1">
<fo:block />
</fo:table-cell>
</fo:table-row>
<fo:table-row height="2.6in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block>
<fo:block>
<fo:external-graphic border-collapse="separate" border="0.5pt solid black" content-width="scale-to-fit" content-height="scale-to-fit" width="2.6in" height="2.6in" src="ref_70_746019226" />
</fo:block>
</fo:block>
</fo:table-cell>
</fo:table-row>
<fo:table-row height="0.45in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block-container>
<fo:block>
<fo:block-container>
<fo:block font-style="italic" font-size="9pt" font-family="TimesNewRomanPSMT">
<fo:inline font-weight="bold">24-5. </fo:inline>
<fo:inline font-weight="normal" margin-left="2pt">
Axial T1WI shows multiple small cutaneous NFs
<external-graphic xmlns="http://www.w3.org/1999/XSL/Format"; src="white_solid" width="0.14in" height="0.09in" content-height="0.09in" content-width="0.14in" />
in an adult with NF1.
</fo:inline>
</fo:block>
</fo:block-container>
</fo:block>
</fo:block-container>
</fo:table-cell>
</fo:table-row>
<fo:table-row height="7pt">
<fo:table-cell number-columns-spanned="2">
<fo:block />
</fo:table-cell>
</fo:table-row>
<fo:table-row height="2.6in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block>
<fo:block>
<fo:external-graphic border-collapse="separate" border="0.5pt solid black" content-width="scale-to-fit" content-height="scale-to-fit" width="2.6in" height="2.6in" src="ref_69_1976726847" />
</fo:block>
</fo:block>
</fo:table-cell>
</fo:table-row>
<fo:table-row height="0.45in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block-container>
<fo:block>
<fo:block-container>
<fo:block font-style="italic" font-size="9pt" font-family="TimesNewRomanPSMT">
<fo:inline font-weight="bold">24-6. </fo:inline>
<fo:inline font-weight="normal" margin-left="2pt">
T1C+FS scan in the same case shows the cutaneous NFs enhance strongly
<external-graphic xmlns="http://www.w3.org/1999/XSL/Format"; src="white_solid" width="0.14in" height="0.09in" content-height="0.09in" content-width="0.14in" />
.
</fo:inline>
</fo:block>
</fo:block-container>
</fo:block>
</fo:block-container>
</fo:table-cell>
</fo:table-row>
<fo:table-row height="7pt">
<fo:table-cell number-columns-spanned="2">
<fo:block />
</fo:table-cell>
</fo:table-row>
<fo:table-row height="2.6in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block>
<fo:block>
<fo:external-graphic border-collapse="separate" border="0.5pt solid black" content-width="scale-to-fit" content-height="scale-to-fit" width="2.6in" height="2.6in" src="ref_24_329140081" />
</fo:block>
</fo:block>
</fo:table-cell>
</fo:table-row>
<fo:table-row height="0.45in">
<fo:table-cell>
<fo:block />
</fo:table-cell>
<fo:table-cell>
<fo:block-container>
<fo:block>
<fo:block-container>
<fo:block font-style="italic" font-size="9pt" font-family="TimesNewRomanPSMT">
<fo:inline font-weight="bold">24-7. </fo:inline>
<fo:inline font-weight="normal" margin-left="2pt">Optic nerve glioma in NF1 (top), axial T2WI (bottom) show fusiform enlargement of the optic nerve. Nerve sheaths are moderately patulous.</fo:inline>
</fo:block>
</fo:block-container>
</fo:block>
</fo:block-container>
</fo:table-cell>
</fo:table-row>
</fo:table-body>
</fo:table>
</fo:static-content>
<fo:flow font-size="10.5pt" font-family="any" flow-name="xsl-region-body">
<fo:block-container hyphenation-remain-character-count="3" hyphenation-push-character-count="3" language="en" hyphenate="true" font-family="any" font-size="10.5pt" id="group-Familial Tumor Syndromes">
<fo:block-container>
<fo:block-container>
<fo:block text-align="justify" space-before="6pt">"Localized" NF1 is caused by a focal sporadic somatic mutation that is not transmitted genetically.</fo:block>
</fo:block-container>
<fo:block-container>
<fo:block keep-with-next="always" space-before="9pt" hyphenate="false" margin-left="-15pt" font-weight="normal" font-family="any" font-size="14pt">Pathology</fo:block>
<fo:block text-align="justify" space-before="3pt">A variety of nonneoplastic as well as benign and malignant tumors are associated with NF1. Each is discussed below.</fo:block>
<fo:block text-align="justify" space-before="6pt" font-weight="normal" font-size="10.5pt">
<fo:inline font-family="any">Nonneoplastic CNS Lesions.</fo:inline>
<fo:inline font-weight="normal">Multiple waxing and waning dysplastic white matter lesions on T2/FLAIR MRI are commonly identified in patients with NF1 (see below). Histopathologically these lesions represent myelin vacuolization and dysgenesis, not hamartomas.</fo:inline>
<fo:block text-align="justify" space-before="6pt">Uncommon nonneoplastic CNS lesions include macrocephaly and subependymal glial nodules. Hydrocephalus occurs in 10-15% of cases. Dural ectasia may cause dilatation of the optic nerve sheaths, Meckel cave, or internal auditory canals. And we start adding abitrary text here. We'll need some exceptionally splendiforous words to sound sophisticated</fo:block>
<fo:block text-align="justify" space-before="6pt">Arteriopathy occurs in at least 6% of cases. The most common manifestation is progressive intimal fibrosis of the supraclinoid internal carotid arteries resulting in moya-moya. Both intra- and extracranial aneurysms and arteriovenous fistulae occur in NF1 but are relatively rare. The vertebral arteries are more commonly affected than the carotid arteries.</fo:block>
</fo:block>
<fo:block text-align="justify" space-before="6pt" font-weight="normal" font-size="10.5pt">
<fo:inline font-family="any">Nervous System Neoplasms.</fo:inline>
<fo:inline font-weight="normal">A spectrum of both benign and malignant peripheral nerve tumors occurs in NF1. All involve tumorigenesis of neural crest-derived cells</fo:inline>
<fo:block text-align="justify" font-weight="normal" font-size="10.5pt" space-before="6pt" text-indent="18pt">
<fo:inline font-style="italic" font-weight="normal">Neurofibromas.</fo:inline>
<fo:inline margin-left="4pt" font-weight="normal">
A spectrum of NF1-associated neurofibromas (NFs) occurs. Tumors derived from skin sensory nerves are designated as dermal or
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">cutaneous neurofibromas</inline>
. Cutaneous neurofibromas increase with age so over 95% of acults with NF1 have one or more lesions. Cutaneous NFs are benign tumors that are mostly composed of Schwann cells and fibroblasts. Most are localized, well-circumscribed, discrete but unencapsulated tumors restricted to a single nerve ending.
</fo:inline>
</fo:block>
<fo:block text-align="justify" space-before="6pt">
Less commonly, tumors within larger nerves appear as a more diffuse mass within the dermis (
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">"diffuse" cutaneous neurofibroma</inline>
).
</fo:block>
<fo:block text-align="justify" space-before="6pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">Plexiform neurofibromas</inline>
(PNFs) are virtually pathognomonic of NF1. PNFs are generally large, bulky tumors that are usually associated with major nerve trunks and plexi. PNFs are found in 30-50% of patients with NF1. PNFs appear as "rope-like" diffusely-infiltrating noncircumscribed lesions that resemble a "bag of worms."
</fo:block>
<fo:block text-align="justify" space-before="6pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">Spinal neurofibromas</inline>
are found in approximately 40% of patients with NF1.
</fo:block>
<fo:block text-align="justify" space-before="6pt">Histologically, NFs are comprised of small ovoid to spindled cells with dark wavy nuclei in a variably myxoid or collagenous background and are S100 positive. Nuclear atypia or rare mitotic figures in isolation should not be construed as signs of malignancy.</fo:block>
<fo:block text-align="justify" font-weight="normal" font-size="10.5pt" space-before="6pt" text-indent="18pt">
<fo:inline font-style="italic" font-weight="normal">Malignant Peripheral Nerve Sheath Tumors.</fo:inline>
<fo:inline margin-left="4pt" font-weight="normal">
While most PNFs remain benign, between 10-15% become malignant. Deep-seated PNFs are at particular risk for development
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">MPNST</inline>
. MicroRNA misregulation appears to be a critical event in the malignant transformation of PNFs.
</fo:inline>
</fo:block>
<fo:block text-align="justify" space-before="6pt">
MPNSTs that occur in the setting of NF1 tend to occur at a younger age and may also include rhabdomyoblastic and other heterologous elements. These tumors--referred to as
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">malignant Triton tumors</inline>
--are very characteristic of NF1.
</fo:block>
<fo:block text-align="justify" font-weight="normal" font-size="10.5pt" space-before="6pt" text-indent="18pt">
<fo:inline font-style="italic" font-weight="normal">Gliomas.</fo:inline>
<fo:inline margin-left="4pt" font-weight="normal">
The vast majority of gliomas in NF1 are
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">pilocytic astrocytomas</inline>
. While they can arise anywhere in the CNS, the optic nerve is the most common site (optic pathway "glioma" or OPG). OPG occurs in 15-20% of patients with NF1 and can be uni- or bilateral. Some OPGs involve the optic chiasm and optic tracts. In contrast to most sporadic diffusely-infiltrating pontine "gliomas," NF1-associated gliomas of the medulla, tectum, and pons are typically more benign.
</fo:inline>
</fo:block>
<fo:block text-align="justify" space-before="6pt">
Approximately 20% of NF1-associated gliomas are malignant. These include
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">diffusely-infiltrating ("low grade") fibrillary astrocytoma</inline>
,
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">anaplastic astrocytoma</inline>
, and
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">glioblastoma multiforme</inline>
.
</fo:block>
</fo:block>
<fo:block text-align="justify" space-before="6pt" font-weight="normal" font-size="10.5pt">
<fo:inline font-family="any">Non-CNS Neoplasms.</fo:inline>
<fo:inline font-weight="normal">NF1 is associated with an increased risk of leukemia (especially juvenile myelomonocytic leukemia and myelodysplastic syndromes), gastrointestinal stromal tumors (6%), and adrenal or extra-adrenal pheochromocytoma (0.1-5%).</fo:inline>
<fo:block text-align="left" font-size="10pt" font-family="any" hyphenate="false" space-before="6pt" keep-together.within-page="always" border="0.6pt solid black" background-color="#FFE8F0">
<fo:block space-before="5pt" keep-with-next="always" display-align="center" font-size="10pt" font-weight="bold" font-family="any" background-color="#FFE8F0">
<fo:block line-height="1.0" text-align="center" padding-before="2.5pt" margin-right="0.0pt">NF1-ASSOCIATED NEOPLASMS</fo:block>
</fo:block>
<fo:block margin-right="10pt">
<fo:list-block line-height="0.95" padding-after="5pt" provisional-label-separation="3pt" provisional-distance-between-starts="8pt">
<fo:list-item space-after="2pt" space-before="3pt" font-size="10pt" font-family="any">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block />
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">Common</inline>
</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Cutaneous neurofibromas (95% of adults)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Plexiform neurofibroma (30%)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Spinal neurofibromas</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item space-after="2pt" space-before="3pt" font-size="10pt" font-family="any">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block />
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">Less Common</inline>
</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Optic pathway glioma (15-20%)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="16pt">
<fo:list-item-label end-indent="label-end()">
<fo:block line-height="0.81" font-size="10.5pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-family="any" font-style="normal" font-weight="normal">â¦</inline>
</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">80% pilocytic astrocytoma</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Other astrocytomas (20%)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="16pt">
<fo:list-item-label end-indent="label-end()">
<fo:block line-height="0.81" font-size="10.5pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-family="any" font-style="normal" font-weight="normal">â¦</inline>
</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Diffusely-infiltrating fibrillary astrocytoma (WHO grade II)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="16pt">
<fo:list-item-label end-indent="label-end()">
<fo:block line-height="0.81" font-size="10.5pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-family="any" font-style="normal" font-weight="normal">â¦</inline>
</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Anaplastic astrocytoma (WHO grade III)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="16pt">
<fo:list-item-label end-indent="label-end()">
<fo:block line-height="0.81" font-size="10.5pt">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-family="any" font-style="normal" font-weight="normal">â¦</inline>
</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Glioblastoma multiforme</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item space-after="2pt" space-before="3pt" font-size="10pt" font-family="any">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block />
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">
<inline xmlns="http://www.w3.org/1999/XSL/Format"; font-weight="bold">Rare But Important</inline>
</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Malignant peripheral nerve sheath tumor (develop in 10-15% of PNFs)</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Rhabdomyosarcoma</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Juvenile chroic myeloid leukemia</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Juvenile xanthogranuloma</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Gastrointestinal stromal tumor</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Melanoma</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Thyroid medullary carcinoma</fo:block>
</fo:list-item-body>
</fo:list-item>
<fo:list-item margin-left="9pt">
<fo:list-item-label end-indent="label-end()" line-height="0.95">
<fo:block font-size="11pt">â¢</fo:block>
</fo:list-item-label>
<fo:list-item-body start-indent="body-start()">
<fo:block line-stacking-strategy="line-height" line-height="0.95">Pheochromocytoma</fo:block>
</fo:list-item-body>
</fo:list-item>
</fo:list-block>
</fo:block>
</fo:block>
</fo:block>
</fo:block-container>
</fo:block-container>
</fo:block-container>
</fo:flow>
</fo:page-sequence>
</fo:root>
---------------------------------------------------------------------
To unsubscribe, e-mail: fop-users-unsubscr...@xmlgraphics.apache.org
For additional commands, e-mail: fop-users-h...@xmlgraphics.apache.org
